Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Four leading healthcare academics in Oxford have received a prestigious national award.

© Shutterstock

The University of Oxford professors have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their “outstanding contribution to clinical and applied health and social care research”.

The successful candidates are all prominent researchers in the NIHR Oxford Biomedical Research Centre (BRC).

Together, the University of Oxford, Oxford Brookes University, Oxford University Hospitals NHS Foundation Trust and Oxford Health NHS Foundation Trust make up the Oxford Academic Health Science Centre (Oxford AHSC), a partnership that coordinates clinical and academic excellence across the partners.

Senior Investigators are appointed from NIHR Investigators through annual competitions, informed by the advice of an international panel of experts. In total, more than 300 Senior Investigators have now been appointed, with the number of active Senior Investigator awards maintained at around 200. They form part of the NIHR Faculty.

The new NIHR Senior Investigators are:

  • Professor Helen McShane, Director of the NIHR Oxford Biomedical Research Centre; Professor of Vaccinology, Nuffield Department of Medicine
  • Professor Ann Sarah Walker, Professor of Medical Statistics and Epidemiology, Nuffield Department of Medicine
  • Professor Matthew Costa, Professor of Orthopaedic Trauma, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
  • Professor Richard McManus, Professor of Primary Care, Nuffield Department of Primary Care Health Sciences

As well as the new appointments, three professors who had previously held awards were designated Emeritus Senior Investigators.

Read more (NIHR Oxford BRC website)

Similar stories

Cancer Research UK to invest £11 million into cancer science in Oxford

A £11 million Cancer Research UK investment has been awarded to the University of Oxford and Oxford-based NHS to catalyse the translation of its world-leading cancer research for patient benefit.

Review highlights risk factors associated with violence in schizophrenia

Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).

An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections

First comprehensive analysis of global impact of antimicrobial resistance (AMR) estimates resistance itself caused 1.27 million deaths in 2019 - more deaths than HIV/AIDS or malaria - and that antimicrobial-resistant infections played a role in 4.95 million deaths.

Attention and memory deficits persist for months after recovery from mild Covid

Researchers from Oxford’s Department of Experimental Psychology and Nuffield Department of Clinical Neurosciences have shown that people who have had Covid but don’t complain of long Covid symptoms in daily life nevertheless can show degraded attention and memory for up to 6-9 months.

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

New book expands the horizons of brain research

A pioneering book from Professor Zoltán Molnár and Yale Professors Tamas Horvath and Joy Hirsch to be released on 1 February 2022 addresses the fundamental relationship between the body, brain and behaviour.